A Phase IV Prospective Safety Surveillance Cohort Study Of ACAM2000 In Deploying Military Personnel.

Trial Profile

A Phase IV Prospective Safety Surveillance Cohort Study Of ACAM2000 In Deploying Military Personnel.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2016

At a glance

  • Drugs ACAM 2000 (Primary) ; Smallpox vaccine
  • Indications Smallpox
  • Focus Adverse reactions
  • Sponsors Sanofi; sanofi pasteur
  • Most Recent Events

    • 18 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 17 Mar 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov.
    • 17 Mar 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top